THE ADVANTAGES OF THE SANCO TEST
Assessment of changes in the number and structure of all 23 pairs of chromosomes
A small sample of maternal blood is sufficient
Performed in Poland
Maximum 5 business days turnaround
The lowest test failure rate on the market
CE-IVD certificate for the entire process.
Patient consent form and report available in English language
WHY TO CHOOSE THE SANCO PRENATAL TEST?
- TEST INDICATIONS
Learn more about the most important indications to perform non-invasive prenatal SANCO Test
SANCO test is based on the VeriSeq technology from Illumina Inc. (USA) - the sequencing solution world leader. The method helps to maintain high effectiveness of the testing, even at 1% of fetal fraction (the concentration of placental cfDNA in plasma). No result was observed only for less than 1% of tests performed.
THE SANCO TEST COMPARED WITH OTHER PRENATAL APPROACHES
Traditional screenings, like ultrasound or first trimester combined (PAPP-A) test, in comparison with the SANCO Test, have lower sensitivity and a 20 times higher false positive rate. Invasive methods, such as amniocentesis, give a diagnostic result, but they carry 0,1-2% risk of miscarriage and time to get the result is almost three times longer than provided in the SANCO Test. In the invasive testings, similarly as in the SANCO Test, all 23 pairs of fetal chromosomes are analyzed for their correct number and structure. Both types of tests can detect deletion syndromes covering at least 7 Mbp. This resolution is similar to the karyotype amniotic fluid testing (so-called amniocentesis).